News
The ability to command a room, have hushed conversations with loved ones, or even something as simple as answering the phone — these are all things Robin Leaper had to learn anew after amyotrophic ...
20h
GlobalData on MSNMTPA’s Radicava shows long-term benefit in ALS trials
MTPA's oral therapy Radicava (edaravone) has shown decreased functional decline and improved survival in long-term ALS trials ...
Jodi O’Donnell-Ames founded Hope Loves Company to provide support, resources, and community to children affected by ALS.
Summary: A new study has uncovered why some motor neurons resist degeneration in ALS while others succumb. Researchers found ...
The ketamine product KETARx made by PharmaTher has been approved by the FDA for use in surgical pain management.
4h
The Chosun Ilbo on MSNU.S. Defense, Health Secretaries Ace 100 Push-Ups, 50 Pull-Ups in 5 Minutes
A physical fitness challenge named the “Pete and Bobby Challenge” was held on the 19th at a massive gym facility in the U.S.
A strong performance from APA’s gas transmission and storage business contributed to a 6.4% lift in EBITDA for the company, ...
The Japanese launch builds on ClearStrand-ASD’s successful rollout across the United States, where it is now available in 49 states. YAC Bio will partner with hospital systems in Japan to facilitate ...
Morning Overview on MSN19h
The real potential of brain-computer interfaces
Brain-computer interfaces (BCIs) are emerging as a groundbreaking technology that has the potential to revolutionize the way humans interact with machines. By bridging the gap between human cognition ...
The Driving and Vehicle Licensing Agency (DVLA) could slap drivers with a £1,000 fine if they fail to report certain health ...
Texas senators approved several bills Monday, one of which included another attempt at blocking hemp-derived THC products.
Host Tylah Tully is joined in this episode by Argenica Therapeutics (ASX:AGN) managing director Dr Liz Dallimore, who shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results